“Evaluation of the Effect of Intravitreal Bevacizumab (Avastin) in Patients with Diabetic Macular Edema”, Nep J Oph, vol. 12, no. 2, pp. 236–244, Oct. 2020, doi: 10.3126/nepjoph.v12i2.28959.